Frontier Medicines adds three to executive team

South San Francisco-based Frontier Medicines, a biopharmaceutical company, has named Kevin Webster as chief scientific officer, Johannes Hermann as chief technology officer and James Winkler as head of degrader technologies. Frontier Medicines' backers include Deerfield Management, Droia Oncology Ventures and MPM Capital.

PeopleNorth AmericaUSBriefs